TickerFactsScreenerDevelopers

ELITE PHARMACEUTICALS INC /NV/ (ELTP) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2011: $1.55M2012: -$394.1K2013: -$1.94M2016: -$2.77M2017: -$7.88M2018: -$4.81M2019: -$6.79M2020: -$1.79M2021: $3.19M2022: $6.51M2023: $3.34M2024: -$3.24M2025: $7.46M$7.46M
2011Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$7.46M+330.5%
2024-$3.24M-196.9%
2023$3.34M-48.7%
2022$6.51M+103.8%
2021$3.19M+278.0%
2020-$1.79M+73.6%
2019-$6.79M-41.2%
2018-$4.81M+39.0%
2017-$7.88M-185.1%
2016-$2.77M—
2013-$1.94M-393.1%
2012-$394.1K-125.4%
2011$1.55M—